Gabapentin
- Generic Name
- Gabapentin
- Brand Names
- Gralise, Neurontin
- Drug Type
- Small Molecule
- Chemical Formula
- C9H17NO2
- CAS Number
- 60142-96-3
- Unique Ingredient Identifier
- 6CW7F3G59X
- Background
Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993. It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures - today it is also widely used to treat neuropathic pain. Gabapentin has some stark advantages ...
- Indication
In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older. In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or...
- Associated Conditions
- Partial-Onset Seizures, Peripheral Neuropathic Pain, Postherpetic Neuralgia
- Associated Therapies
- -
Preemptive Oral Gabapentin 600 mg in Reducing Morphine Requirement After Non Obstetric Lower Abdominal Surgery
- Conditions
- Interventions
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2021-09-13
- Lead Sponsor
- Indonesia University
- Target Recruit Count
- 72
- Registration Number
- NCT04434430
- Locations
- 🇮🇩
Cipto Mangunkusumo Cental National Hospital, Jakarta, DKI Jakarta, Indonesia
Gabapentin and Tizanidine for Insomnia in Chronic Pain
- Conditions
- Interventions
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 24
- Registration Number
- NCT04429347
- Locations
- 🇺🇸
Center for Pain Medicine, UC San Diego, La Jolla, California, United States
Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- State University of New York at Buffalo
- Target Recruit Count
- 68
- Registration Number
- NCT04429022
- Locations
- 🇺🇸
Millard Fillmore Suburban Hospital, Williamsville, New York, United States
Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS)
- Conditions
- Interventions
- First Posted Date
- 2020-04-14
- Last Posted Date
- 2020-04-14
- Lead Sponsor
- Medstar Health Research Institute
- Target Recruit Count
- 10
- Registration Number
- NCT04345432
Gabapentin for Perioperative Pain Relief in Surgical Abortion
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- University of Nevada, Las Vegas
- Target Recruit Count
- 219
- Registration Number
- NCT04292171
- Locations
- 🇺🇸
Birth Control Care Center, Las Vegas, Nevada, United States
Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI
- Conditions
- Interventions
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- MetroHealth Medical Center
- Target Recruit Count
- 27
- Registration Number
- NCT04256603
- Locations
- 🇺🇸
MetroHealth, Cleveland, Ohio, United States
Multimodal Pain Study in Free Flap Patients
- Conditions
- Interventions
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT04246697
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Multimodal Analgesia Effect on Post Surgical Patient
- Conditions
- Interventions
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 60
- Registration Number
- NCT04240626
- Locations
- 🇺🇸
UC Davis Health, Sacramento, California, United States
Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 74
- Registration Number
- NCT04230980
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
- First Posted Date
- 2019-11-25
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT04176419
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.